Baby food industry violated laws on breast milk substitute

Image
Press Trust of India New Delhi
Last Updated : Dec 02 2016 | 1:57 PM IST
The baby food industry has violated the Infant Milk Substitutes Act (IMS) that bans promotion of breast-milk substitutes at least 54 times between 2008 and 2016, according to an industry watchdog.
The survey conducted by Breastfeeding Support for Indian Mothers, a Facebook group with more than 29,000 members, showed that more than half of the 950 mothers who delivered in private hospitals were given artificial baby milk. Out of these, 2/3rd were given without their knowledge.
It also found that children were given the formula without the knowledge of their mother.
Any kind of promotion for baby foods and feeding bottles for children aged upto 2 years, including advertisements inducement of sales, pecuniary benefits to doctors or their associations including sponsorship is banned under the IMS Act.
"Aggressive marketing by baby food companies and sponsorship contribute to increased use of formula at the time of birth and later by undermining breastfeeding and every effort should be made to curb such invasive promotion," Dr Arun Gupta, Central Coordinator, BPNI and Regional Coordinator, IBFAN Asia said.
"Despite the directives issued by the government of India, the baby food manufacturing bottle companies are still violating the IMS Act," Gupta said.
According to Euromonitor report, 10,847 tonnes of standard infant formula (0-6 month's age group) was sold in India in 2012, which is 10,847,000 kg of milk powder.
"Converting this into containers of 400 grams, it means India sells about 27 Million containers of 400 gms each year, almost equal to its babies born. Going by the estimated growth of formula industry in 2022, this figure will be 32.7 million," he said.
According to the World Health Organisation (WHO), artificial feeding is an established risk factor for child health like causing more of diarrhoea, respiratory or newborn infections, allergies as well as obesity and adult health diseases like diabetes and heart disease.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 02 2016 | 1:57 PM IST

Next Story